Rare Disease Treatment in China: Approval ≠ Access
China is approving rare-disease therapies faster, but approval does not always mean immediate access for international patients. This video explains the administrative realities of cross-border healthcare in China — from MDT pre-reviews and medical record translation to self-pay logistics and continuity-of-care planning.
#MedicalConcierge #RareDisease #ChinaHealthcare #CrossBorderHealthcare #HealthcareLogistics #GlobalHealth